This is cool, but not sure when it would ever come in handy 🤷

Good to see this study published with iPSC-NK cells that use both the novel NK cell-CAR and non-cleavable CD16 developed by our group: pubmed.ncbi.nlm.nih.gov/30082067/ pubmed.ncbi.nlm.nih.gov/31856277/

Really great story about another aspect of "Regenerative Medicine". Bionic Hand Sparks Resilience in Patient After Electrocution Accident today.ucsd.edu/story/bionic-h…

This is very good.

This is going to be brutal for essentially all academic health centers. For those interested, see the new: grants.nih.gov/grants/guide/n…. I am interested to know where the funds not going to IDC will go instead. Best if they funded more grants with higher paylines, but I am skeptical

Does anyone know if the Congressionally Directed Medical Research Program (CDMRP) is kaput? They fund lots of cancer research. Now all CDMRP websites are gone, as below. Any ideas? Musk and friends likely ended these to fund their tax cuts, but let me know if any other ideas.

#ResistanceUnited Advertisement at a London bus stop… ya gotta love the British

Thanks for highlighting this detailed protocol from our group. I know many have used our methods to make engineered iPSC-derived NK cells- including a group in Thailand I just met with yesterday. I hope these details can help others with interest.

This is brilliant

Worth posting from UC San Diego Health colleague Alexander Khalessi, MD, MBA.

Sending this out to my colleague Aaron Goodman - “Papa Heme”

Wondering how NIH funding cuts could impact #cancer patients and their families? The University of California sheds light on this issue, featuring Moores member Dan Kaufman, who highlights the crucial immune-based T cell therapy research happening at our institution:

At UC San Diego, Dr. Dan Kaufman is developing immune-based therapies using engineered natural killer (NK) cells to combat aggressive liver cancer. With NIH support, his work offers new hope—but without it, life-saving advancements could stall. bit.ly/4bwGHrG

Gotta say, for anyone who has cared for patients with Mucor, this looks like pretty good news: A humanized antibody against mucormycosis targets angioinvasion and augments the host immune response | Science Translational Medicine science.org/doi/10.1126/sc…

I am looking forward to attending NK2025 in Tasmania (!)👀. Always a great meeting. More info: NK2025.au #NK2025

Love this

Nice to see a rationale approach promoted here. Seems like good advice. 5 Science-Backed Longevity ‘Hacks’ That Don’t Cost a Fortune nytimes.com/2025/04/10/wel…

Congrats to the Minnesota Timberwolves This is great.

I must say I am very disappointed by the lack of analysis from Steve Kornacki about what precincts played a big role in this Pope vote

Things are looking up on the public health front